John Iwanicki comments on the Ariad Pharmaceuticals Inc. v. Eli Lilly & Co. case.

October 8, 2009

Mr. Iwanicki discusses the significance of the Federal Circuit rehearing the Ariad Pharmaceuticals v. Eli Lilly case and who should be watching this case, in an IP Law 360 article titled: Fed. Circ. To Weigh In On Written Description Rule.

Posted: October 8, 2009